Research Article
BibTex RIS Cite

Year 2021, Volume: 22 Issue: 1, 53 - 56, 30.04.2021
https://doi.org/10.4274/meandros.galenos.2021.65002

Abstract

References

  • 1. Tomino Y, Cooper ME, Kurtz TW, Shimizu Y. Experimental models of type-2 diabetic nephropathy. Exp Diabetes Res 2012; 2012: 218917.
  • 2. Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol 2012; 35: 164-74.
  • 3. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, et al. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 2010; 411: 700-4.
  • 4. Hatano M, Hodges RE, Evans TC, Hagemann RF, Leeper DB, Bean WB, et al. Urinary excretion of pantothenic acid by diabetic patients and by alloxan-diabetic rats. Am J Clin Nutr 1967; 20: 960-7.
  • 5. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-26.
  • 6. Depeint F, Bruce WR, Shangari N, Mehta R, O’Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact 2006; 163: 94-112.
  • 7. Etensel B, Ozkisacik S, Ozkara E, Karul A, Oztan O, Yazici M, et al. Dexpanthenol attenuates lipid peroxidation and testicular damage at experimental ischemia and reperfusion injury. Pediatr Surg Int 2007; 23: 177-81.
  • 8. Wojtczak L, Slyshenkov VS. Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals--the role of glutathione. Biofactors 2003; 17: 61-73.
  • 9. Slyshenkov VS, Piwocka K, Sikora E, Wojtczak L. Pantothenic acid protects jurkat cells against ultraviolet light-induced apoptosis. Free Radic Biol Med 2001; 30: 1303-10.
  • 10. Halvorsen O, Skrede S. Regulation of the biosynthesis of CoA at the level of pantothenate kinase. Eur J Biochem 1982; 124: 211-5.
  • 11. Slyshenkov VS, Dymkowska D, Wojtczak L. Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett 2004; 569: 169-72.
  • 12. Bayrak O, Seckiner I, Solakhan M, Karakok M, Erturhan SM, Yagci F. Effects of intravesical dexpanthenol use on lipid peroxidation and bladder histology in a chemical cystitis animal model. Urology 2012; 79: 1023-6.
  • 13. Gulle K, Ceri NG, Akpolat M, Arasli M, Demirci B. The effects of dexpanthenol in streptozotocin-induced diabetic rats: histological, histochemical and immunological evidences. Histol Histopathol 2014; 29: 1305-13.
  • 14. Demirci B, Demir O, Dost T, Birincioglu M. Protective effect of vitamin B5 (dexpanthenol) on cardiovascular damage induced by streptozocin in rats. Bratisl Lek Listy 2014; 115: 190-6.
  • 15. Altintas R, Parlakpinar H, Beytur A, Vardi N, Polat A, Sagir M, et al. Protective effect of dexpanthenol on ischemia-reperfusion-induced renal injury in rats. Kidney Blood Press Res 2012; 36: 220-30.
  • 16. Tutun B, Elbe H, Vardi N, Parlakpinar H, Polat A, Gunaltili M, et al. Dexpanthenol reduces diabetic nephropathy and renal oxidative stress in rats. Biotech Histochem 2019; 94: 84-91.

Protective Effect of Vitamin B5 (Dexpanthenol) on Nephropathy in Streptozotocin Diabetic Rats

Year 2021, Volume: 22 Issue: 1, 53 - 56, 30.04.2021
https://doi.org/10.4274/meandros.galenos.2021.65002

Abstract

Objective: This study aimed to evaluate the effects of vitamin B5 [dexpanthenol, DEX] treatment on the kidney in a streptozotocin (STZ) diabetes animal model.
Materials and Methods: Twenty-four Wistar rats were randomised in one of the four groups: Group 1 served as control, and group 2 was administered high-dose DEX (300 mg/kg/day) as a safety group. Diabetes was induced by intraperitoneal injection of a single dose of STZ (50 mg/kg) in groups 3 and 4. In group 4, DEX was administered as well. All groups were followed up for 6 weeks. Histopathological analyses were performed on renal tissue using periodic acid-Schiff and Hematoxylin Eosin stains.
Results: Microscopic evaluation of the kidney revealed that the rats demonstrated kidney damage 6 weeks after STZ administration. However, high-dose and longterm DEX administration alone did not damage renal tissue; moreover, kidney damage was prevented if DEX was administered in the early phase of diabetes.
Conclusion: DEX could be a safe and cost-effective vitamin for the prevention of diabetes complications.

References

  • 1. Tomino Y, Cooper ME, Kurtz TW, Shimizu Y. Experimental models of type-2 diabetic nephropathy. Exp Diabetes Res 2012; 2012: 218917.
  • 2. Moon JY, Jeong KH, Lee TW, Ihm CG, Lim SJ, Lee SH. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol 2012; 35: 164-74.
  • 3. Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, et al. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta 2010; 411: 700-4.
  • 4. Hatano M, Hodges RE, Evans TC, Hagemann RF, Leeper DB, Bean WB, et al. Urinary excretion of pantothenic acid by diabetic patients and by alloxan-diabetic rats. Am J Clin Nutr 1967; 20: 960-7.
  • 5. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008; 51: 216-26.
  • 6. Depeint F, Bruce WR, Shangari N, Mehta R, O’Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact 2006; 163: 94-112.
  • 7. Etensel B, Ozkisacik S, Ozkara E, Karul A, Oztan O, Yazici M, et al. Dexpanthenol attenuates lipid peroxidation and testicular damage at experimental ischemia and reperfusion injury. Pediatr Surg Int 2007; 23: 177-81.
  • 8. Wojtczak L, Slyshenkov VS. Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals--the role of glutathione. Biofactors 2003; 17: 61-73.
  • 9. Slyshenkov VS, Piwocka K, Sikora E, Wojtczak L. Pantothenic acid protects jurkat cells against ultraviolet light-induced apoptosis. Free Radic Biol Med 2001; 30: 1303-10.
  • 10. Halvorsen O, Skrede S. Regulation of the biosynthesis of CoA at the level of pantothenate kinase. Eur J Biochem 1982; 124: 211-5.
  • 11. Slyshenkov VS, Dymkowska D, Wojtczak L. Pantothenic acid and pantothenol increase biosynthesis of glutathione by boosting cell energetics. FEBS Lett 2004; 569: 169-72.
  • 12. Bayrak O, Seckiner I, Solakhan M, Karakok M, Erturhan SM, Yagci F. Effects of intravesical dexpanthenol use on lipid peroxidation and bladder histology in a chemical cystitis animal model. Urology 2012; 79: 1023-6.
  • 13. Gulle K, Ceri NG, Akpolat M, Arasli M, Demirci B. The effects of dexpanthenol in streptozotocin-induced diabetic rats: histological, histochemical and immunological evidences. Histol Histopathol 2014; 29: 1305-13.
  • 14. Demirci B, Demir O, Dost T, Birincioglu M. Protective effect of vitamin B5 (dexpanthenol) on cardiovascular damage induced by streptozocin in rats. Bratisl Lek Listy 2014; 115: 190-6.
  • 15. Altintas R, Parlakpinar H, Beytur A, Vardi N, Polat A, Sagir M, et al. Protective effect of dexpanthenol on ischemia-reperfusion-induced renal injury in rats. Kidney Blood Press Res 2012; 36: 220-30.
  • 16. Tutun B, Elbe H, Vardi N, Parlakpinar H, Polat A, Gunaltili M, et al. Dexpanthenol reduces diabetic nephropathy and renal oxidative stress in rats. Biotech Histochem 2019; 94: 84-91.
There are 16 citations in total.

Details

Primary Language English
Subjects Anatomy
Journal Section Research Article
Authors

Nazlı Gülriz Çeri

Kanat Gülle

Mehmet Araslı

Meryem Akpolat Ferah

Buket Demirci

Publication Date April 30, 2021
Published in Issue Year 2021 Volume: 22 Issue: 1

Cite

EndNote Çeri NG, Gülle K, Araslı M, Akpolat Ferah M, Demirci B (April 1, 2021) Protective Effect of Vitamin B5 (Dexpanthenol) on Nephropathy in Streptozotocin Diabetic Rats. Meandros Medical And Dental Journal 22 1 53–56.